Scholars have previously studied sectoral systems of innovation to analyze the
interdependence of innovation activities and capabilities in an industry, but such studies …

Traditionally, the dominant form of innovation required that firms generate ideas internally
and subsequently develop and market resulting products themselves. Yet, this mode of …

Historically, research and development (R&D) in the pharmaceutical sector has
predominantly been an in-house activity. To enable investments for game changing late …

This paper investigates the adoption of Open Innovation in the bio-pharmaceutical industry,
studying through which organisational modes it is put into practice and how these modes …

Over the last decade, open innovation has impacted and enhanced firms' collaboration
strategies and public policy programs as this new 'paradigm shift'emerged from business' …

This article focuses on the paradigm shift of the global biopharmaceutical sector's utiliza-tion
of open innovation models to optimize drug development. Leveraging four exemplars, this …

Companies have historically invested in large research and development departments to
drive innovation and provide sustainable growth. This model, however, is eroding due to a …

A fundamental shift has occurred in the ways that ideas become marketable goods and
services, and it has great implications for new businesses. Chesbrough describes how …

The purpose of this study is to evaluate the dynamics of Open Innovation related to the
healthcare industry in Boston for the sake of helping firms successfully identify, get, and use …

OVERVIEW: The future of open innovation will be more extensive, more collaborative, and
more engaged with a wider variety of participants. It will extend beyond technology to …